Sc , which is produced by conformational change of a normal host protein, PrP C . It is currently unknown whether PrP Sc molecules exist in a unique conformation or whether they are able to undergo additional conformational changes. 
Creutzfeldt-Jakob disease, bovine spongiform encephalopathy, chronic wasting disease, and scrapie belong to an unusual group of central nervous system infections called the prion diseases (1) . Much experimental evidence supports the hypothesis that the infectious agents of these diseases contain no informational nucleic acids (2) . Instead, biochemical studies indicate that prions are composed primarily of a misfolded protein designated PrP Sc , 1 which is able to induce the conformational change of a normal host glycoprotein termed PrP C into new PrP Sc molecules through a self-propagating mechanism (3, 4) .
The conformational state(s) of PrP Sc molecules that are able to induce the conversion of other PrP molecules is currently unknown (5) . Purification of infectious prions from scrapieinfected Syrian hamsters revealed that fractions enriched for scrapie infectivity primarily contain PrP molecules relatively resistant to protease digestion (PrPres) (6) . PrPres molecules have been found only in prion-infected cells, so it is possible that PrPres is equivalent to PrP Sc . In support of this hypothesis, denaturation of PrPres molecules by various biochemical procedures causes parallel decreases in prion infectivity (7) . However, the ratio of PrPres molecules to prion LD 50 infectivity units in purified prion preparations has been estimated to be 1:100,000 or less (5) . Therefore, it is also possible that infectious PrP
Sc molecules compose only a minor fraction of the PrP molecules contained in such preparations. Several studies indirectly support this alternative view. 1) It is possible to denature and refold PrP molecules into protease-resistant forms that are not infectious (8) ; 2) prion infectivity can be propagated in vivo by inocula lacking detectable PrPres (9) ; and 3) conformation-dependent immunoassay experiments show that prion-infected brains contain both protease-sensitive and protease-resistant forms of PrP Sc -like molecules (10) . Therefore, it is important to identify the conformational state(s) of PrP Sc molecules that induce the formation of PrPres molecules in vitro and propagate infectivity in vivo.
Another important question is whether PrP Sc molecules exist in a unique and static conformation or whether they are capable of undergoing additional conformational changes that would allow them to exist in different states at equilibrium. Three independent observations support the view that PrP Sc molecules might have interconvertible structures and that these structures might be controlled by copper or zinc ions. 1) Copper and zinc ions control the strain-dependent electrophoretic mobility of PrPres in Creutzfeldt-Jakob disease brain homogenates (11) ; 2) copper increases the level of PrPres detected in scrapie-infected mouse brain homogenates (12) ; and 3) copper enhances the reversal of scrapie inactivation by guanidine hydrochloride (13) .
In Membrane Fractionation-P2 membranes were obtained using a modification of a previously described protocol (14) . All procedures were performed at 4°C. Six frozen Syrian hamster brains (Harlan Sprague Dawley, Inc., Indianapolis, IN) were homogenized in 40 ml of buffer containing 0.3 M sucrose and 5 mM Tris (pH 7.5) plus EDTA-free Complete ® protease inhibitor mixture tablets (Roche Applied Science) with 10 strokes of a motor-driven Teflon/glass homogenizer. The crude homogenate was centrifuged at 800 ϫ g for 20 min. The supernatant was divided evenly into two separate tubes and centrifuged at 9000 ϫ g for 20 min. The resulting pellets (P2) were resuspended as follows: one pellet with 15 ml of 10 mM Tris (pH 8.0) plus EDTA-free Complete® tablets and the other pellet with 15 ml of phosphate-buffered saline without calcium and magnesium plus EDTA-free Complete® tablets. The resuspended pellets were then homogenized with a Potter homogenizer using 10 strokes each for both loose and tight pestles. This identical procedure was used to obtain corresponding P2 fractions from 12 Prnp 0/0 mouse brains. Aliquots of all fractions were frozen at Ϫ70°C for subsequent experiments.
Preparation of PrP- (27) (28) (29) (30) -A sample containing 200 l of 1% (w/v) Sc237 scrapie-infected hamster brain homogenate in Buffer A (10 mM Tris (pH 8.0) and 1% Triton X-100) was treated with 50 g/ml proteinase K (Roche Applied Science) for 30 min at 25°C. Proteolytic digestion was terminated by addition of 10 mM phenylmethylsulfonyl fluoride (Roche Applied Science). Following proteinase K digestion, the sample was centrifuged at 100,000 ϫ g for 1 h at 4°C. The pellet was washed twice with Buffer A and resuspended in 500 l of the specified test buffers using a Bandolin Sonoplus ultrasonicator (Amtrex Technologies, Saint-Laurent, Quebec, Canada) set for 10 1-s pulses.
PrP Sc Protease Resistance Assay-The protease resistance of PrP Sc was assayed using 0.2% (w/v) scrapie-infected brain homogenate in 10 mM Tris (pH 8.0) and 0.5% Triton X-100 plus other components as specified in each experiment. Samples were incubated for 10 min at 37°C with continuous shaking. Following incubation, samples were treated with 50 g/ml proteinase K for 1 h at 37°C unless specified otherwise. The samples were then boiled in SDS sample loading buffer for 10 min prior to electrophoresis. In Vitro PrPres Amplification Assay-In vitro PrPres amplification was performed using hamster P2 subfractions as described previously (14) , with the following modifications. Samples containing 50 l of P2 membranes were incubated with 50 l of 0.1% (w/v) Sc237 scrapieinfected brain homogenate and diluted into the specified test buffers plus 0.5% Triton X-100. The mixtures were incubated at 37°C for 16 h with continuous shaking. Following incubation but prior to proteinase K digestion, 150 mM NaCl was added to samples incubated without salt. All samples were treated with 50 g/ml proteinase K and incubated for 1 h at 37°C. The digested samples were then boiled in SDS sample loading buffer for 10 min prior to electrophoresis.
Electrophoresis and Immunoblotting-Electrophoresis and immunoblotting were performed as described previously (14) . Briefly, SDS-PAGE was performed on 1.5-mm 12% acrylamide gels with an acrylamide/bisacrylamide ratio of 29:1. Following electrophoresis, proteins were transferred to an ethanol-charged, buffer-equilibrated polyvinylidene difluoride membrane (Millipore Corp., Bedford, MA) using a Hoeffer TE 50X transfer unit (Amersham Biosciences) set at 1.5 A for 2 h. Transferred membranes were treated with 0.2 N NaOH for 10 min, rinsed 3 ϫ 5 min with TBST (10 mM Tris (pH 7.2), 150 mM NaCl, and 0.1% Tween 20) , and blocked with 5% Carnation nonfat milk powder in TBST for 1 h. Blocked membranes were incubated with 200 ng/ml monoclonal antibody 3F4 (Signet Laboratories, Inc., Dedham, MA) in TBST overnight at 4°C, washed 4 ϫ 10 min with TBST, incubated with horseradish peroxidase-labeled sheep anti-mouse IgG secondary antibody (Amersham Biosciences) diluted 1:5000 in TBST for 30 min at 4°C, and washed again 4 ϫ 10 min with TBST. The blots were developed with ECL reagent (Pierce), sealed in plastic covers, and exposed to Super RX film (Fujifilm, Tokyo, Japan). Exposed films were developed automatically in a Kodak M35A X-Omat film processor. Relative molecular masses in kilodaltons, based on the migration of prestained protein standards (Bio-Rad), are indicated to the right of each figure.
Chromogenic Protease Assay-Proteinase K activity was measured as described previously for elastase (15) , with the following modifications. Proteinase K was resuspended in various test buffers at a final concentration of 10 g/ml. The chromogenic substrate succinyl-Ala-AlaAla-p-nitroanilide (Peptides International Inc., Louisville, KY) was added (from a 125 mM stock solution in 1-methyl-2-pyrrolidinone (Acros Organics, Somerville, NJ)) to obtain a final concentration of 1 mM succinyl-Ala-Ala-Ala-p-nitroanilide. The samples were mixed and incubated at 25°C. Absorbance measurements of triplicate samples at 410 nm were made at 10-min intervals, and the means Ϯ S.E. were calculated using Microsoft Excel.
RESULTS

Ionic Strength and Copper Control the Protease Resistance of PrP
Sc Molecules-In our first series of experiments, we examined the effects of ionic strength and copper concentration on the protease resistance of PrP Sc molecules in crude scrapieinfected brain homogenates. Unexpectedly, we discovered that PrP Sc molecules were protease-sensitive when incubated at low ionic strength in the absence of transition metals (Fig. 1 , second panel, first lane). The protease resistance of PrP Sc molecules was restored by addition of NaCl at concentrations Ͼ50 mM ( Fig. 1 , second panel, second and eleventh through fourteenth lanes). A variety of other salts, including LiCl, NaCl, KCl, NaF, NaBr, and NaI, also restored the protease resistance of PrP Sc molecules in scrapie-infected brain homogenates at concentrations Ͼ50 mM (data not shown), indicating that the induction of protease resistance requires a minimum level of ionic strength rather than the presence of a particular monovalent salt. Next, we tested the ability of copper ions to restore the protease resistance of PrP Sc molecules under conditions of low ionic strength. Sc molecules derived from different strains of prions display differential susceptibilities to proteinase K digestion (16) as well as denaturation by guanidine hydrochloride denaturation (17) and polyamidoamine dendrimers (18) . Therefore, we examined whether the effects of ionic strength and copper on the protease resistance of PrP Sc molecules are restricted to a particular prion strain or animal species. We found that the protease resistance of PrP Sc molecules derived from both RML-infected mouse and Sc237-infected hamster brains was affected by salt and copper in a similar manner (Fig.  1, compare second and third panels) . These results indicate that the effects of ionic strength and copper are not limited to PrP Sc molecules derived from a particular prion strain or animal species.
To quantitate the differences in PrP Sc protease resistance observed under various conditions, we performed protease digestion assays using varying amounts of proteinase K. Our results show that PrP Sc molecules were Ͼ20-fold more sensitive to proteinase K digestion when incubated at low ionic strength and in the absence of copper compared with PrP Sc molecules incubated either at high ionic strength or in the presence of copper ( Fig. 2A) . For comparison, PrP C molecules in normal brain homogenates were ϳ100-fold more sensitive to proteinase K digestion than PrP
Sc molecules incubated at low ionic strength and ϳ2000-fold more protease-sensitive than PrP Sc molecules incubated at high ionic strength (data not shown).
Ionic strength and copper could conceivably control the protease resistance of PrP Sc either by changing the conformation of PrP Sc molecules or by inhibiting the proteolytic activity of proteinase K in our assays. To test the possibility that proteinase K might be inhibited by salt or copper, we measured proteinase K activity under different buffer conditions using succinyl-Ala-Ala-Ala-p-nitroanilide, a non-conformational chromogenic substrate (15) . The results show that proteinase K activity was not affected by addition of 150 mM NaCl and was only mildly reduced by addition of 100 M CuCl 2 (Fig. 2B) . In addition, we tested whether ionic strength or copper influences the general pattern of protein degradation in brain homogenates digested with varying concentrations of proteinase K and found no significant change (Fig. 2C) . Taken together, these control experiments indicate that the effects of ionic strength and copper on the protease resistance of PrP Sc molecules cannot be attributed to nonspecific inhibition of proteinase K activity. Therefore, these chemical factors must influence either the tertiary or quaternary conformation of PrP Sc molecules directly.
Copper and Zinc Ions Specifically Control PrP Sc Conformation-Copper is one of several transition metals normally found in physiological fluids. Previous studies showed that recombinant PrP molecules have Ͼ1000-fold greater affinity for binding to copper ions than to other metal ions (19, 20) and that PrP C molecules bind copper ions in vivo (21) . To investigate the specificity of the effect of copper on PrP Sc conformation, we tested the abilities of various metal salts to induce PrP Sc protease resistance at low ionic strength. When tested at a concentration of 100 M, copper and zinc ions were most effective at inducing PrP Sc protease resistance, whereas cobalt and nickel ions were less effective, and magnesium, calcium, chromium, manganese, iron, silver, and aluminum ions were ineffective (Fig. 3) . Additional dose-response experiments showed that the metal concentration at which PrP Sc achieved 50% (22) (23) (24) . Additional studies indicate that PrP also contains a second high affinity copper-binding site outside of the octapeptide repeat domain (20, (25) (26) (27) . We investigated whether the octapeptide repeat domain is required for the effects of ionic strength and copper on PrP Sc conformation by studying purified truncated PrP-(27-30) molecules. PrP-(27-30) molecules lacking the N-terminal octapeptide repeat domain were generated and partially purified by limited proteolysis and ultracentrifugation (28) . Ionic strength and copper altered the protease sensitivity of purified PrP-(27-30) molecules in a manner similar to crude full-length PrP Sc molecules (Fig. 4) Sc molecules and facilitate buffer changes. The results of these buffer exchange experiments show that increasing the ionic strength increased the protease resistance of PrP Sc molecules, whereas decreasing the ionic strength reduced the protease resistance of PrP Sc molecules (Fig. 5A) . To investigate the reversibility of PrP Sc conformational changes induced by transition metals, we used EDTA to chelate copper molecules in a stoichiometric manner. The results of these chelator experiments show that increasing the concentration of free copper increased the protease resistance of PrP Sc molecules and decreasing the free copper concentration had the opposite effect (Fig. 5B) . Thus, our findings indicate that the PrP Sc conforma- tional changes induced by either ionic strength or copper are reversible.
In Vitro PrPres Amplification Requires High Ionic Strength-As described above, the conformational state(s) of PrP Sc molecules able to convert other PrP molecules is currently unknown. Therefore, we investigated whether any of the PrP Sc conformers that we identified could induce the conversion of PrP C substrates into PrPres molecules. We used a previously described in vitro PrPres amplification technique (14) and enriched membrane preparations to study this question. Fig. 6 shows that efficient in vitro PrPres amplification required high ionic strength. Furthermore, this requirement for salt could not be circumvented by addition of either copper or zinc ions (Fig. 6) . These experiments indicate that either 1) the protease-resistant PrP Sc conformation induced by high ionic strength is the only conformation able to induce the conversion of other PrP molecules in our experiments, or 2) salt is required for a different role in the mechanism of PrPres formation. Sc molecules to become protease-resistant and able to induce the conversion of other PrP molecules. The minimum concentration of salt required for PrP Sc protease resistance was ϳ50 mM, and it is likely that, above this concentration, salts can shield electrostatic repulsions between like charged domains of PrP Sc molecules. Interestingly, Surewicz and co-workers (29 -31) have shown that salt is required for the structural transition of truncated recombinant PrP molecules into ␤-sheet-rich amyloid fibrils. Thus, electrostatic interactions may be important in two distinct aspects of PrP folding: 1) conversion of PrP C into PrP Sc and 2) maintenance of a protease-resistant PrP Sc conformation. How might the influence of salt on PrP Sc conformation be relevant in living cells, which maintain constant levels of ionic strength? We propose two possible scenarios. 1) Normally, PrP molecules covalently attach to lipid raft membranes through a C-terminal glycophosphatidylinositol anchor (32) (33) (34) and also associate with membranes through non-anchor interactions (35) (36) (37) . Therefore, within cells, PrP Sc molecules may exist in relatively non-polar microenvironments with dielectric constant (⑀) values similar to those of low ionic strength aqueous solutions. A subset of PrP Sc molecules may be protease-sensitive under such conditions. 2) Alternatively, it is possible that ionic molecules other than monovalent salts control electrostatic interactions with PrP in vivo, and binding to these specific molecules may induce PrP Sc to become protease-resistant. Candidate ionic PrP-binding molecules include acidic lipids, glycosaminoglycans, nucleic acids, and proteins with charged binding surfaces (36 -54) . This proposed scenario is analogous to the process of actin polymerization. In vitro, G-actin can be polymerized by adding salts, and F-actin can be depolymerized by dilution into low salt buffer. However, living cells cannot use
DISCUSSION
FIG. 2. Proteinase K digestion assays.
A, proteinase K digestion of crude scrapie-infected hamster brain homogenates. Samples containing equal amounts of crude Sc237-infected brain homogenates (0.2%, w/v) in 10 mM Tris (pH 8.0) and 0.5% Triton X-100 were incubated with proteinase K (PK) at various concentrations for 1 h at 37°C. Some samples also contained 150 mM NaCl or 0.1 mM CuCl 2 as indicated. B, measurement of proteinase K activity in various buffers using the chromogenic protease assay described under "Experimental Procedures." The buffers tested were composed of 10 mM Tris (pH 8) with no addition (Ⅺ), with 1 mM EDTA (pH 8) (ࡗ), with 0.1 mM CuCl 2 (q), or with 150 mM NaCl (‚). C, proteinase K digestion of normal hamster brain homogenates. Samples of crude brain homogenates (0.2%, w/v) in 10 mM Tris (pH 8.0) and 0.5% Triton X-100 were incubated with proteinase K at various concentrations. Some samples also contained 150 mM NaCl or 0.1 mM CuCl 2 as indicated. All samples were treated with proteinase K for 10 min at 25°C, subjected to denaturing SDS-PAGE electrophoresis, and visualized by silver staining. The molecular mass of proteinase K is indicated by the arrow. M, molecular weight markers. ionic strength to regulate actin polymerization, and instead use actin-binding proteins to control the assembly, disassembly, organization, and movement of actin filaments (55) .
On the basis of epitope detection studies, other workers have proposed that a subset of PrP Sc molecules in prion-infected brain tissue are protease-sensitive (10). Our findings offer additional evidence that PrP Sc molecules can be protease-sensitive, but also suggest that this conformation may not be able to induce the conversion of other PrP molecules. It is also interesting to consider that structural interconvertibility might facilitate the activity of an infectious protein molecule. For instance, the conversion of a PrP Sc molecule from one conformation to another might simultaneously drive the conversion of a bound PrP C molecule into PrP Sc .
Copper and Zinc Enhance the Protease Resistance of PrP Sc
Molecules-Our experiments also show that 30 -40 M concentrations of copper and zinc ions enhance the protease resistance of PrP Sc molecules at low ionic strength. Physiological concentrations of copper and zinc ions at neuronal synapses (where PrP molecules are localized) can reach ϳ20 and 300 M, respectively (56) . Both copper and zinc ions are released from synaptic vesicles during neurotransmission. Approximately 15-30% of the released zinc ions are chemically exchangeable (57) , whereas the chemical state of released copper ions is not currently known. Thus, the conformation of PrP Sc molecules might be influenced by exposure to physiological concentrations of specific transition metals in vivo. Interestingly, most of the other transition metals tested did not cause an increase in the protease resistance of PrP Sc , and cobalt and nickel caused only small increases in protease resistance. This specificity among transition metals suggests that the PrP Sc metal-binding site may preferentially recognize the 3d 10 4s 1 or 3d 10 4s 2 electron orbital arrangement of copper and zinc. It is worth noting that superoxide dismutase (58) and amyloid-␤-(1-42) (59, 60), proteins that can misfold and that are implicated in the pathogenesis of the neurodegenerative diseases amyotrophic lateral Samples with sequential additions were incubated for an additional 10-min period after the second buffer component was added. Upon completion of all incubations, all samples were digested with 50 g/ml proteinase K for 1 h at 37°C.
FIG. 3. Effects of transition metals on the protease resistance of PrP
Sc . The protease resistance of PrP Sc in samples containing equal amounts of crude Sc237 scrapie-infected hamster brain homogenates was assayed by proteinase K digestion and Western blotting as described under "Experimental Procedures." Proteinase K digestion was performed in various buffers containing 10 mM Tris (pH 8.0) and 0.5% Triton X-100 plus control additives (150 mM NaCl and 1 mM EDTA (150 mM NaCl) and 0 mM NaCl and 1 mM EDTA ()) or the specified metal salts (0.1 mM).
FIG. 4. Protease resistance of native and truncated PrP
Sc molecules. Samples containing either crude Sc237 scrapie-infected hamster brain homogenate or purified truncated PrP-(27-30) were resuspended and incubated for 10 min at 37°C in 10 mM Tris (pH 8.0) and 0.5% Triton X-100. Some samples also contained 150 mM NaCl or 0.1 mM CuCl 2 as indicated. The specified samples were digested with 50 g/ml proteinase K (PK) for 1 h at 37°C. sclerosis and Alzheimer's disease, respectively, also preferentially bind copper and zinc over other transition metals.
As described above, some prior studies have also shown that copper and zinc ions affect PrP Sc conformation (11) (12) (13) , whereas other studies suggest that PrP Sc molecules do not bind copper (61) . Our study provides evidence that the effects of copper and zinc on PrP Sc conformation are significantly more potent at low ionic strength. Under such conditions, micromolar concentrations of copper and zinc ions increased the protease resistance of PrP Sc by Ͼ20-fold. Interestingly, an analogous reciprocal interaction between ionic strength and zinc ions also appears to control the precipitation of amyloid-␤-(1-42)-peptide (62) . We also found that, unlike the protease-resistant PrP Sc conformer induced by salt, the protease-resistant PrP Sc conformer induced by copper could not drive PrPres amplification in vitro. Thus, it seems unlikely that transition metals influence the conversion-inducing activity of PrP Sc molecules in cells. Metal ion occupancy may instead stabilize PrP Sc molecules, delaying their clearance from cells. Such a mechanism might account for the observation that PrP Sc molecules immunopurified from Creutzfeldt-Jakob disease brains contain aberrantly high levels of manganese and zinc (63) as well as observations that correlate environmental transition metal levels with prion disease (64) .
Our results also show that copper and zinc ions enhance the protease resistance of full-length PrP Sc and purified truncated PrP-(27-30) molecules. Thus, copper and zinc ions appear able to bind PrP Sc molecules at sites beyond residues 23-90. Such sites may be located around histidine residues at positions 96 and 111 (20) . Interestingly, binding of either copper or zinc ions is critical for the aggregation and neurotoxicity of a 21-amino acid PrP peptide fragment encompassing residues 106 -126 (65). However, whether residues 106 -126 are required for the effects of copper on PrP Sc conformation remains undetermined. Whereas our studies have focused upon the effects of copper and zinc on PrP Sc conformation, others have previously shown that copper also affects the conformation, trafficking, and superoxide dismutase-like activity of PrP C (66 -70) . Thus, transition metals may control multiple aspects of prion protein metabolism in both normal and disease states.
Reversible Changes in PrP Sc Structure-It is currently debated whether PrP Sc molecules are formed by nucleated polymerization (71) or a template assistance mechanism (72) . As noted by Caughey and co-workers (73), the nucleated polymerization of some proteins is reversible. Therefore, if nucleated polymerization governs the aggregation of PrP Sc molecules, it may be possible to use nondenaturing conditions to control the equilibrium distribution of PrP Sc molecules between aggregated and non-aggregated states (73) . Our results identify ionic strength and metal ion occupancy as two conditions that cause reversible effects on PrP Sc conformation and conformation-inducing activity. However, additional kinetic and biophysical studies will be needed to confirm whether these conditions affect the aggregation state of PrP Sc molecules. General Considerations-The protease resistance of PrP Sc molecules has been a central feature of prion research since 1982, when protease digestion was used as a key step in the purification of scrapie prions (6) . The protease resistance of PrP Sc molecules has also contributed greatly to our understanding that the pathogenesis of prion disease involves conformational change (74) and to the development of molecular diagnostic tests for clinical prion disease (75, 76) . It is interesting to reflect with hindsight that the difference in protease resistance between PrP C and PrP Sc molecules might not have been immediately apparent had low ionic strength buffers been used to prepare brain homogenates in early experiments examining this biochemical property.
Our discovery that PrP Sc molecules have interconvertible structures may have some additional implications beyond those discussed above. First, the interconvertibility of PrP Sc molecules suggests that it may be possible to alter the conformation of PrP Sc molecules therapeutically, i.e. to identify chemical compounds that shift protease-resistant PrP Sc molecules with conversion-inducing activity into a protease-sensitive, inert conformation. This possibility offers hope that the prions already deposited in the brains of patients at the time of diagnosis could be either inactivated or removed. Second, our results suggest that low ionic strength buffers with chelators may be preferred diluents for proposed prion disinfectants composed of proteolytic enzymes such as subtilisin (77) and papain (77) . Finally, our findings with PrP Sc raise the possibility that other amyloidogenic proteins and peptides might also possess interconvertible molecular structures.
